Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Apheresis Market, by Procedure
1.4.2 North America Apheresis Market, by Product
1.4.3 North America Apheresis Market, by Method
1.4.4 North America Apheresis Market, by End User
1.4.5 North America Apheresis Market, by Country
1.4.6 North America Apheresis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.2.4 Approval and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Apheresis Market by Procedure
4.1 North America Donor/Automated Market by Country
4.2 North America Therapeutic Market by Country
Chapter 5. North America Apheresis Market by Product
5.1 North America Disposable & Reagents Market by Country
5.2 North America Devices Market by Country
5.3 North America Software Market by Country
Chapter 6. North America Apheresis Market by Method
6.1 North America Centrifugation Market by Country
6.2 North America Membrane Separation Market by Country
6.3 North America Selective Adsorption Market by Country
Chapter 7. North America Apheresis Market by End User
7.1 North America Blood Centers Market by Country
7.2 North America Hospitals Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Apheresis Market by Component
8.1 North America Plasma (Plasmapheresis) Market by Country
8.2 North America Platelets (Plateletpheresis) Market by Country
8.3 North America Leukocytes (Leukapheresis or leukopheresis) Market by Country
8.4 North America Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country
8.5 North America RBC's (Erythropheresis) Market by Country
Chapter 9. North America Apheresis Market by Country
9.1 US Apheresis Market
9.1.1 US Apheresis Market by Procedure
9.1.2 US Apheresis Market by Product
9.1.3 US Apheresis Market by Method
9.1.4 US Apheresis Market by End User
9.1.5 US Apheresis Market by Component
9.2 Canada Apheresis Market
9.2.1 Canada Apheresis Market by Procedure
9.2.2 Canada Apheresis Market by Product
9.2.3 Canada Apheresis Market by Method
9.2.4 Canada Apheresis Market by End User
9.2.5 Canada Apheresis Market by Component
9.3 Mexico Apheresis Market
9.3.1 Mexico Apheresis Market by Procedure
9.3.2 Mexico Apheresis Market by Product
9.3.3 Mexico Apheresis Market by Method
9.3.4 Mexico Apheresis Market by End User
9.3.5 Mexico Apheresis Market by Component
9.4 Rest of North America Apheresis Market
9.4.1 Rest of North America Apheresis Market by Procedure
9.4.2 Rest of North America Apheresis Market by Product
9.4.3 Rest of North America Apheresis Market by Method
9.4.4 Rest of North America Apheresis Market by End User
9.4.5 Rest of North America Apheresis Market by Component
Chapter 10. Company Profiles
10.1 Fresenius SE & Co. KGaA
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.5.2 Geographical Expansions:
10.2 Terumo Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.4.2 Geographical Expansions:
10.2.4.3 Approvals and Trials:
10.3 Charles River Laboratories International, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Acquisition and Mergers:
10.4 Haemonetics Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Approvals and Trials:
10.5 Asahi Kasei Medical Co., Ltd.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Kaneka Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.7 Cerus Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.8 B. Braun Melsungen AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.9 Nikkiso Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental Analysis
10.9.4 Research & Development Expense
10.10. SB Kawasumi Laboratories, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
Unique Offerings 